Universal Scientific Industrial (Shanghai) Co., Ltd. (SHA:601231)
China · Delayed Price · Currency is CNY 47.63
+4.32 (9.97%)
At close: Feb 27, 2026
SHA:601231 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 59,195 | 60,615 | 60,730 | 68,470 | 55,254 |
Other Revenue | - | 75.98 | 62.07 | 45.98 | 46.05 |
| 59,195 | 60,691 | 60,792 | 68,516 | 55,300 | |
Revenue Growth (YoY) | -2.46% | -0.17% | -11.27% | 23.90% | 15.94% |
Cost of Revenue | 53,580 | 54,920 | 55,133 | 61,418 | 50,044 |
Gross Profit | 5,615 | 5,771 | 5,659 | 7,098 | 5,256 |
Selling, General & Admin | 1,697 | 1,780 | 1,557 | 1,719 | 1,453 |
Research & Development | 1,901 | 1,908 | 1,807 | 2,019 | 1,625 |
Other Operating Expenses | 12.79 | 114.13 | 77.36 | 55.43 | 49.82 |
Operating Expenses | 3,654 | 3,834 | 3,463 | 3,804 | 3,133 |
Operating Income | 1,962 | 1,936 | 2,196 | 3,294 | 2,123 |
Interest Expense | -347.42 | -391.01 | -400.22 | -235 | -201.33 |
Interest & Investment Income | 593.92 | 517.75 | 379.23 | 226.63 | 179.46 |
Currency Exchange Gain (Loss) | - | -215.82 | -32.02 | 136.34 | -62.66 |
Other Non Operating Income (Expenses) | -213.66 | -10.1 | -16.32 | -8.2 | -4.36 |
EBT Excluding Unusual Items | 1,994 | 1,837 | 2,127 | 3,414 | 2,034 |
Gain (Loss) on Sale of Investments | -25.91 | -11.8 | -27.11 | 31.84 | 44.59 |
Gain (Loss) on Sale of Assets | 160.38 | 7.53 | 6.33 | 2.72 | -9.12 |
Asset Writedown | 10.65 | -2.43 | -0.91 | -49.85 | - |
Other Unusual Items | - | 23.36 | 84.73 | 78.43 | 69.25 |
Pretax Income | 2,139 | 1,854 | 2,190 | 3,477 | 2,139 |
Income Tax Expense | 310.52 | 209.65 | 239.98 | 417.21 | 282.17 |
Earnings From Continuing Operations | 1,829 | 1,644 | 1,950 | 3,060 | 1,857 |
Minority Interest in Earnings | 24.47 | 8.31 | -1.86 | -0.02 | 1.28 |
Net Income | 1,853 | 1,652 | 1,948 | 3,060 | 1,858 |
Net Income to Common | 1,853 | 1,652 | 1,948 | 3,060 | 1,858 |
Net Income Growth | 12.16% | -15.16% | -36.34% | 64.69% | 6.81% |
Shares Outstanding (Basic) | 2,181 | 2,174 | 2,189 | 2,186 | 2,186 |
Shares Outstanding (Diluted) | 2,206 | 2,203 | 2,239 | 2,267 | 2,239 |
Shares Change (YoY) | 0.14% | -1.59% | -1.22% | 1.26% | 2.95% |
EPS (Basic) | 0.85 | 0.76 | 0.89 | 1.40 | 0.85 |
EPS (Diluted) | 0.84 | 0.75 | 0.87 | 1.35 | 0.83 |
EPS Growth | 12.00% | -13.79% | -35.56% | 62.65% | 3.75% |
Free Cash Flow | - | 2,948 | 5,274 | 1,764 | -2,617 |
Free Cash Flow Per Share | - | 1.34 | 2.35 | 0.78 | -1.17 |
Dividend Per Share | - | 0.230 | 0.270 | 0.430 | 0.260 |
Dividend Growth | - | -14.82% | -37.21% | 65.39% | -48.00% |
Gross Margin | 9.49% | 9.51% | 9.31% | 10.36% | 9.50% |
Operating Margin | 3.31% | 3.19% | 3.61% | 4.81% | 3.84% |
Profit Margin | 3.13% | 2.72% | 3.20% | 4.47% | 3.36% |
Free Cash Flow Margin | - | 4.86% | 8.67% | 2.57% | -4.73% |
EBITDA | 2,970 | 2,945 | 3,205 | 4,159 | 2,970 |
EBITDA Margin | 5.02% | 4.85% | 5.27% | 6.07% | 5.37% |
D&A For EBITDA | 1,009 | 1,009 | 1,009 | 864.43 | 846.81 |
EBIT | 1,962 | 1,936 | 2,196 | 3,294 | 2,123 |
EBIT Margin | 3.31% | 3.19% | 3.61% | 4.81% | 3.84% |
Effective Tax Rate | 14.51% | 11.31% | 10.96% | 12.00% | 13.19% |
Revenue as Reported | - | - | - | 68,516 | 55,300 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.